Sigyn Therapeutics, Inc.
SIGY· OTC
SIGYSigyn Therapeutics, Inc.
Filed Aug 14, 2017 · 10-Q · 45 days after period end · 0001615774-17-004391
| Metric | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|
| Revenue | $432.53K | — | $18.44K |
| Net Income | -$967.49K | -$885.70K | -$483.27K |
| EPS Diluted | -$0.02 | -$0.03 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sigyn Therapeutics, Inc. · CIK 1642159 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 14, 2017 · 45 d after period end
